Safety and efficacy of affinity-purified, anti-tumor necrosis factor-α, ovine fab for injection (CytoFab) in severe sepsis

Nursing and Health Professions

• Adverse Event 10%
• Antibodies 10%
• Antigen 10%
• Blood Level 10%
• Cytofab 100%
• Dose 10%
• Human Albumin 10%
• Incidence 10%
• Injection 100%
• Intensive Care Unit 10%
• Interleukin 6 30%
• Interleukin 8 10%
• Laboratory 10%
• Loading Drug Dose 10%
• Lung Lavage 20%
• Measurement 10%
• Mortality Rate 10%
• Patient 50%
• Placebo 69%
• Sepsis 100%
• Shock 30%
• Tumor Necrosis Factor 100%
• Ventilator 30%
• Vital Sign 10%

Medicine and Dentistry

• Adverse Event 10%
• Antibodies 10%
• Bronchoalveolar Lavage Fluid 10%
• Cytofab 100%
• Fragment Antigen-Binding 10%
• Human Albumin 10%
• Incidence 10%
• Inflammatory Mediator 10%
• Injection 100%
• Intensive Care Unit 10%
• Interleukin 6 30%
• Interleukin 8 10%
• Laboratory 10%
• Loading Drug Dose 10%
• Lung Lavage 10%
• Measurement 10%
• Mortality Rate 10%
• Organ 10%
• Patient 50%
• Placebo 69%
• Sepsis 100%
• Serum 20%
• Shock (Circulatory) 30%
• Tumor Necrosis Factor 100%
• Vital Sign 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 10%
• Antibodies 10%
• Cytofab 100%
• Fragment Antigen-Binding 10%
• Human Albumin 10%
• Incidence 10%
• Interleukin 6 30%
• Interleukin 8 10%
• Mortality Rate 10%
• Placebo 69%
• Sepsis 100%
• Sheep 100%
• Shock 30%
• Tumor Necrosis Factor 100%